Navigation Links
With Prostate Cancer: Waiting for Symptoms Is Not an Option
Date:7/1/2008

NEW YORK, July 1 /PRNewswire/ -- Prostate cancer is the second leading cause of death among American males, but when caught early, prostate cancer has a 90% cure rate.

According to Dr. David Samadi, Chief, Division of Robotics and Minimally Invasive Surgery, Department of Urology, at Mount Sinai Medical Center, "The key to fighting prostate cancer is not to wait until there are warning signs, because by then it may be too late."

The tendency of prostate cancer to grow without causing noticeable symptoms leads doctors to recommend that men over 50 get screened every year. However, Dr. Samadi recommends that anyone with a strong family history of the disease or other risk factors get screened at age 40.

Routine screening for prostate cancer consists of a PSA (prostate-specific antigen) blood test and a digital rectal exam. Most doctors regard a PSA score of less than 4.0 as normal, however, Dr. Samadi regards a jump in PSA velocity to be a warning sign. For example, an increase in the PSA velocity from 0.8 one year to 1.6 the following may be a red flag requiring a biopsy to test for cancer cells. If there is need for treatment, there are surgical options for removal of the prostate with varying outcomes that can dramatically impact the recovery process and quality of life.

"The most common treatment for prostate cancer is surgical removal of the prostate or prostatectomy traditionally done by open surgery," Dr. Samadi says. "While results of open surgery are generally excellent, there are distinct downsides. For one thing, the surgeon makes an 8- to 10-inch incision to remove a 2-inch organ, which causes enough blood loss that about 20 percent of patients require a blood transfusion. That large incision also means more pain and a higher risk of infection."

Robotic prostate surgery is virtually "bloodless" and involves five small "keyhole" incisions in the patient's abdomen, through which fine instruments are inserted, along w
'/>"/>

SOURCE Dr. David Samadi, Mount Sinai Medical Center
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Red wine compound shown to prevent prostate cancer
7. Barbershop Talks Cut Black Mens Prostate Cancer Risk
8. Generic prostate drug helps find high-risk cancers early
9. Finasteride unlikely to induce high grade prostate cancers
10. Shrinkage of prostate led to overestimation of cancer risk in trial
11. Prostate Cancer Awareness Week to Screen Thousands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... AQUALIPO™ and NaturalFill™ revolutionary new liposuction and fat transfer treatments ... lips all in one minimally invasive treatment. , ... ... of AQUALIPO™ and NaturalFill™ can remove excess fat from the ... help people slim down, reduce facial wrinkling and enhance lips ...
(Date:12/14/2009)... ABBOTT PARK, Ill. and HOLLYWOOD, Fla., Dec. ... ABT ) announced today a definitive agreement ... LIMS ), a leading provider of laboratory ... in cash. ,, The acquisition strengthens ... market, providing advanced web-based applications to help ...
(Date:12/14/2009)... -- Heska Corporation (Nasdaq: HSKA ; ... of veterinary diagnostic and specialty products, today ... Company,s new DRI-CHEM® 7000 Veterinary Chemistry Analyzer ... ) ,, Customers receiving these analyzers have ... analyzer available to the veterinary in-clinic market. ...
(Date:12/14/2009)... Incorporated announced today that it has priced $400 ... a coupon of 6.9%. The notes will be ... 6.984%. The company anticipates using the proceeds from ... purposes. ,, Commenting on the pricing of the ... Officer Kriss Cloninger III commented: "This debt issuance ...
(Date:12/14/2009)... Dental Care (also known as Culver City Dentist ... care in Southern California. We provide treatments in general ... and periodontal treatments. Beverly Hills Dentist and ... with experienced and trusted dentists who provide these treatments ... is one of these trusted dentists. He is best ...
Breaking Medicine News(10 mins):Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4Health News:United Dental Care, Gentle Care, Trusted Dentists 2Health News:United Dental Care, Gentle Care, Trusted Dentists 3
... Sydney and Boston believe they may have identified a gene ... very troublesome problem for people with diabetes. , The liver ... sugar (glucose) levels fall, the liver makes and releases more. ... doesn,t stop making sugar when it should, so blood sugar ...
... and Efficacy Study of Zolpidem Tartrate Sublingual ... As-Needed BasisEvaluation of Ondansetron Augmentation in the ... 21 Transcept Pharmaceuticals, Inc. (Nasdaq: ... focused on the development and commercialization of ...
... ST. PETERSBURG, Fla., May 21 Mosaica Partners ... the Health Information Technology for Economic and Clinical ... healthcare through health information exchange (HIE) in its ... the Economic Stimulus Package for Health Information Exchange." ...
... Patients with Challenging Anatomy Consistent with Superior Results ... New data presented today at EuroPCR from an ... XIENCE V(R) Everolimus Eluting Coronary Stent System demonstrated ... stent thrombosis and major adverse cardiac events (MACE) ...
... assisted reproductive technology should be made aware, researcher says ... to naturally conceived twins, those conceived through assisted reproductive ... admitted to neonatal intensive care, finds a new study. ... twins born in Western Australia between 1994 and 2000. ...
... (OTC Bulletin Board: MLSS), the recognized leader in advanced injection ... is scheduled to be held on Thursday, June 4, 2009 ... as of the close of business on April 10, 2009. ... of Brown, Rudnick, Berlack and Israels located at 7 Times ...
Other Medicine News:Health News:Regulating the sugar factory in diabetes 2Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 2Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 3Health News:Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association 4Health News:Mosaica Partners Briefing Paper Identifies Leading Practices for States and Regions to Leverage ARRA Stimulus Funds for HIE 2Health News:Mosaica Partners Briefing Paper Identifies Leading Practices for States and Regions to Leverage ARRA Stimulus Funds for HIE 3Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 2Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 3Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 4Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 5Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 6Health News:Fertility Treatment Twins More at Risk for Hospitalizations 2Health News:Milestone Scientific to Host 2009 Annual Meeting of Stockholders on Thursday, June 4, 2009 in New York City 2
(Date:12/14/2009)... Dec. 14 Fujirebio Diagnostics Inc., a ... of the Year by the Eastern Technology Council ... Hotel in Philadelphia on Thursday, December 3, 2009. ... the Philadelphia region,s largest technology and life sciences ... the Technology and Life Sciences Community, the awards ...
(Date:12/14/2009)... Dec. 14 Following is a statement ... Consumer Healthcare Products Association (CHPA), regarding today,s release ... Monitoring the Future survey: ,, "Findings released today ... to the need for continued efforts to educate ... to talk to their teens about medicine abuse. ...
(Date:12/14/2009)... Cardinal Health today announced that executives of the company ... Goldman Sachs CEO Unplugged Conference on Jan. ... Center in New York. 28th Annual J.P. ... EST at the Westin St. Francis Hotel in San ... discuss Cardinal Health,s diverse products and services, company performance ...
Breaking Medicine Technology:Fujirebio Diagnostics Named Life Sciences Company of the Year 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 3Cardinal Health Executives to Speak at Two Investor Events in January 2Alcohol Countermeasure Systems Penetrates New Markets Through Acquisition of Seres Ethylometre of France 63155 1Alcohol Countermeasure Systems Penetrates New Markets Through Acquisition of Seres Ethylometre of France 63155 2Targeted therapy prolongs life in patients with HER2 positive breast cancer 63152 1Targeted therapy prolongs life in patients with HER2 positive breast cancer 63152 2New Hope for Brain Spinal Cord Injuries 63150 1New Hope for Brain Spinal Cord Injuries 63150 2
... 12, 2007--Inflazyme,Pharmaceuticals Ltd. (TSX: IZP). As announced ... the Phase 2b CAPSICS study with,IPL512,602 showed ... received drug or placebo. However, the placebo,response ... number of,the end-points, which prompted an examination ...
... at,the Stanford University School of Medicine say they ... that an antidepressant,which previously showed promise in treating ... result in a sustained benefit,for the patients who ... prescribed,antidepressant sold under the brand name Lexapro. In ...
Other Medicine Technology:Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 2Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 3Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 2Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 3
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: